Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?

le Saisho, Yoshifumi
Foilsithe in Int J Mol Sci (2014)

β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes

le Saisho, Yoshifumi
Foilsithe in World J Diabetes (2015)

Alogliptin benzoate for management of type 2 diabetes

le Saisho, Yoshifumi
Foilsithe in Vasc Health Risk Manag (2015)

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

le Saisho, Yoshifumi
Foilsithe in J Clin Med (2014)

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes

le Saisho, Yoshifumi
Foilsithe in Int J Mol Sci (2016)

Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas

le Saisho, Yoshifumi
Foilsithe in Rev Diabet Stud (2016)

Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes

le Saisho, Yoshifumi
Foilsithe in Int J Environ Res Public Health (2018)

Incretin-based therapy and pancreatitis: accumulating evidence and unresolved questions

le Saisho, Yoshifumi
Foilsithe in Ann Transl Med (2018)

SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?

le Saisho, Yoshifumi
Foilsithe in Diseases (2020)

Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited

le Saisho, Yoshifumi
Foilsithe in Endocr Metab Immune Disord Drug Targets (2019)

Ethnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes

le Inaishi, Jun, Saisho, Yoshifumi
Foilsithe in J Clin Med (2017)

Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment

le Sugiyama, Kazutoshi, Saisho, Yoshifumi
Foilsithe in Diseases (2018)

Correction: Sugiyama, K.; et al. Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment. Diseases 2018, 6, 44

le Sugiyama, Kazutoshi, Saisho, Yoshifumi
Foilsithe in Diseases (2018)

Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes

le Nagahisa, Taichi, Saisho, Yoshifumi
Foilsithe in Diabetes Ther (2019)

Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review

le Inaishi, Jun, Saisho, Yoshifumi
Foilsithe in Nutrients (2020)

Response to Comment on: Saisho et al. β-Cell Mass and Turnover in Humans: Effects of Obesity and Aging. Diabetes Care 2013;36:111–117

le Saisho, Yoshifumi, Butler, Alexandra E., Manesso, Erica, Butler, Peter C.
Foilsithe 2013

A new diagnostic strategy for gestational diabetes during the COVID‐19 pandemic for the Japanese population

le Kasuga, Yoshifumi, Saisho, Yoshifumi, Ikenoue, Satoru, Ochiai, Daigo, Tanaka, Mamoru
Foilsithe in Diabetes Metab Res Rev (2020)

C-Reactive Protein, High-Molecular-Weight Adiponectin and Development of Metabolic Syndrome in the Japanese General Population: A Longitudinal Cohort Study

le Saisho, Yoshifumi, Hirose, Hiroshi, Roberts, Rachel, Abe, Takayuki, Kawabe, Hiroshi, Itoh, Hiroshi
Foilsithe 2013

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis

le Sugiyama, Kazutoshi, Meguro, Shu, Saisho, Yoshifumi, Irie, Junichiro, Tanaka, Masami, Itoh, Hiroshi
Foilsithe in Heliyon (2019)

New strategy for diagnosing abnormal glucose tolerance before 24 gestational weeks during the coronavirus disease 2019 pandemic

le Kasuga, Yoshifumi, Saisho, Yoshifumi, Tamagawa, Masumi, Ikenoue, Satoru, Tanaka, Mamoru, Ochiai, Daigo
Foilsithe in J Diabetes Investig (2021)